Conference
58 Development and characterization of novel orally available Hypoxiainducible factor (HIF) signaling inhibitors as dual-mechanism cancer therapeutics
Authors
Schultes C; Alonso J; Encinas-Lopez A; Leber B; Mülbaier M; Thermann R; Thomson D; Wawro S; Janssen B; Lewis J
Volume
8
Publisher
Elsevier
Publication Date
November 1, 2010
DOI
10.1016/s1359-6349(10)71763-8
Conference proceedings
European Journal of Cancer Supplements
Issue
7
ISSN
1359-6349